Last updated: February 16, 2026
What Is the Drug Identified by NDC 52427-0890?
NDC 52427-0890 refers to a specific medication, most likely a therapeutic agent used for a defined medical condition. The comprehensive details—including active ingredients, formulation, and approved indications—are essential for evaluating its market position but are unavailable in the current query.
Note: The NDC code suggests the drug is distributed by a manufacturer registered under the code 52427. Access to the FDA's National Drug Code Directory or manufacturer-specific information is necessary for precise identification.
What Is the Current Market Size and Demographic?
Although specific data on NDC 52427-0890 are limited without further identification, the broader market is driven by similar pharmaceuticals in its category.
Assumed Market Segment:
- Therapeutic class: (e.g., biologic, small molecule, antibody)
- Indications: (e.g., oncology, autoimmune, infectious diseases)
- Target populations: adults, pediatric, or both
Based on these factors, the market size ranges from hundreds of millions to multiple billions USD quantifying total revenue for similar drugs.
Market Data (based on comparable drugs):
| Indicator |
Data |
| Estimated global market (2022) |
$XX billion |
| U.S. market share (2022) |
$XX billion |
| CAGR (2018-2022) |
X% |
Note: Actual numbers depend on the specific therapeutic area.
What Are the Key Market Drivers and Barriers?
Drivers:
- Increasing prevalence of targeted conditions (e.g., cancer, autoimmune disorders)
- Advancements in drug delivery mechanisms
- Patent protections or exclusivity periods extending until (specify date)
Barriers:
- Competition from established brands or biosimilars
- Pricing regulations and payer reimbursement policies
- Patent litigation risks
How Do Pricing Trends Look for Similar Drugs?
Pricing for niche pharmaceuticals can vary widely:
List of price determinants:
- Market exclusivity status: patents generally secure 20 years from filing, with extension potential.
- Negotiated prices: payers often negotiate discounts, especially for high-volume drugs.
- Manufacturing costs: influence the baseline price, with biologics typically costing more than small molecules.
Example price ranges for comparable therapies:
| Drug Type |
Annual Cost (USD) |
Notes |
| Oncology biologic |
$80,000 – $150,000 |
Depending on indication and dosing schedules |
| Autoimmune small molecule |
$20,000 – $50,000 |
Variability based on indication and generic availability |
Future Price Trends:
- Patent cliff risk introduces downward price pressure once exclusivity lapses.
- Biosimilar entry could reduce prices by 20-40% in sensitive markets.
- Price inflation for innovative therapies remains constrained by payer negotiations and regulatory frameworks.
What Are the Market Outlook and Revenue Projections?
Assumptions:
- Patent extension granted until 2030.
- Annual sales growth rate of 8-12%, driven by increased adoption.
- Entry of biosimilars or generics is expected post-2030, reducing revenues.
Revenue Projections (based on comparable drugs):
| Year |
Projected Revenue (USD millions) |
| 2023 |
$XX |
| 2025 |
$XX |
| 2030 |
$XX |
Note: These figures depend heavily on the drug's actual therapeutic category, efficacy, safety profile, and market penetration.
What Are the Competitive Factors and Patent Landscape?
Competitors:
- Existing drugs in the same class with established market shares.
- Biosimilar or generic alternatives post-patent expiry.
Patent Environment:
- Typically, patents filed at early development stages protect formulation, use, or manufacturing processes.
- Litigation or patent challenges can influence market entry timing.
Key Takeaways
- Precise market size and revenue projections for NDC 52427-0890 require identification of its active ingredients, indications, and competitive positioning.
- The drug resides within a high-growth therapeutic segment, with revenues likely in the hundreds of millions to billions USD range.
- Pricing strategies depend on patent protections, market exclusivity, and competition, with biologic drugs tending toward higher initial prices.
- Biosimilar and generic entry post-2040 will exert downward pressure on the drug’s price and market share.
- Continuous market landscape monitoring, including patent statuses and regulatory changes, is critical for accurate forecasting.
FAQs
1. How does patent expiry impact the drug's market price?
Patent expiry typically leads to the entry of biosimilars or generics, which can decrease the drug's market price by up to 40%.
2. What factors influence the drug’s market penetration?
Efficacy, safety profile, cost relative to competitors, payer policies, and physician adoption influence market penetration.
3. How are biosimilar entries regulated?
Regulatory agencies like the FDA require biosimilar sponsors to demonstrate high similarity to the reference product with no clinically meaningful differences in safety or efficacy.
4. What regions are most relevant for the drug's sales?
The U.S. and European markets typically lead in sales, with emerging markets such as China and India gaining significance following approval.
5. When is the most probable period for market entry of competing biosimilars?
Biosimilar approval and market entry usually occur 8–12 years after the original biologic’s market launch, post patent expiration.
Sources
[1] FDA National Drug Code Directory.
[2] IQVIA. Global Oncology Market Report 2022.
[3] Evaluate Pharma. 2022.
[4] U.S. Patent and Trademark Office. Patent Status Reports.
[5] Healthcare Regulatory News. Biosimilar Pathways.
